Coronavirus Live Count Map India
remove_red_eye 519 Views
Coronavirus Live Count Map World
Lack of regulation an ailment for the Indian diagnostic industry
New Delhi, Sep 15 (IANSlife) 70 per cent of clinical decisions are based on a diagnostic report and yet, in India, all it takes to open and run a medical laboratory is a simple shop and establishment act. A largely unregulated environment has left a lot of room for malpractice. It is estimated that there are over 1,00,000 laboratories in India and due to low entry barriers, there is a varying degree of quality and reliability and no minimum standard that is guaranteed to the patient. Patients should research before choosing a lab for their testing needs Recently the media reported an incident in Delhi where it was found that a small non-descript lab was issuing fake COVID reports. Such practices have been rampant in the industry and patients and hospitals need to be alert and choose good labs that are reputed for quality, accuracy, ....read more
Tamil Nadu Model
Join us today on Medtalks with Dr KK Aggarwal COVID edition at 7:00 pm as we discuss the status of COVID-19 in Tamil Nadu and how the state has responded to the pandemic. Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php
World Covid Meter 14th September, Acute manageable immunogenic thrombogenic inflammatory viral disease Pandemic
Cases:1M: April 2, 2 M April 15, 3 M: April 27, 4 M May 8; 5 M 20 May, 6 M 30th May, 7 M 7th June, 8M by 15 June, 9 M 22nd June, 10 M 29th June. 11 M 4th July, 16 M, 17 M 29 July, 18 M 1st August 21 .8 M 16 August, 25 M 30th August, 28 M 10 September, Ground Zero: Wuhan in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 29, 188, 603,Deaths: 928, 325,Recovered: 21,031,679 ,ACTIVE CASES 7,228,599....read more
Prevention is better than cure: Protocols for preventing Covid-19
Prevention, we know, is always better than cure. This age-old adage has stood the test of time and has become all the more relevant now in the current pandemic of coronavirus disease 2019 (COVID‑19), caused by the SARS-CoV-2 virus. It has high transmissibility and has spread rapidly to more than 200 countries. Since December 2019 when it first emerged, around 28 million people worldwide have been infected with the virus. The world is eagerly awaiting a safe and effective vaccine to control the pandemic. However, a vaccine is not likely to be available for public use at least till the next year. The World Health Organization (WHO) is hopeful that the pandemic will last for less than 2 years. How will this virus evolve? We do not know. ....read more
Why do we put on Tilak on the forehead?
The Tilak signifies auspiciousness and invokes a feeling of respect in the wearer and others. It is recognized as a religious mark. Its form and color vary depending on one’s caste, religious sect or the form of worship of the person in question. Tilak is applied on the forehead with sandal paste, sacred ash or kumkum, a red turmeric powder. In a wedding, a Kumkum tilak is applied on the forehead of both the bride and groom. ....read more
Video of The day
Healthcare News Monitor
Tanaz Buhariwalla, India Director, IDA Ireland informs that India and Ireland’s economic and trade ties are growing year on year and highlights that bilateral trade between India and Ireland stood at €1.116 billion from January-December 2019, the highest recorded turnover between any two countries. She also talks about why Ireland is the next ‘speak-to country’ for India, post-Brexit for companies focussed on growing their European market, in an interview with Lakshmipriya Nair What are the opportunities that have opened up for India-Ireland collaborations as a result of the COVID-19 pandemic? It is said that every adversity brings with it the seed of an equal or greater benefit and while COVID-19 has thrown a cloud over the global economy, we have seen numerous opportunities open up between India and Ireland during this time. Most of these are in the life sciences and technology sectors. With the disruption to their supply chain affecting Indian companies, the importance of having a presence in Europe to ensure the security of supply in the future is now in focus. We are in discussion with a number of them who are evaluating the option of setting up a presence in Ireland. This also includes Indian companies offering digital products and aiding digital transformation projects for clients in the West.
NEW DELHI : Hyderabad-based Saptagir Laboratories, part of the ₹900 crore Saptagir Group, on Monday announced an exclusive agreement with Jubilant Generics- a Jubilant Life Sciences company, to manufacture intermediates and Active Pharmaceutical Ingredient (API) for intravenous administered drug Remdesivir. The drug will be produced at its Hyderabad World Health Organization (WHO) GMP certified sterile drug product manufacturing plant, acquired at an investment of ₹75 crore. Remdesivir is an experimental antiviral drug developed by Gilead Sciences, Inc. as a course of treatment for covid-19. Gilead entered into a non-exclusive licensing agreement with Jubilant Life Sciences for distribution to 127 countries. Following this, Jubilant Life Sciences through its subsidiary Jubilant Generics has entered an exclusive agreement with Saptagir Laboratories to manufacture Remdesivir.
Pune: Doctor attacked by 3 in his clinic
The Indian Express
A 65-year-old doctor was allegedly attacked by three persons while treating a patient at his clinic at Wadgaon Budruk area. The victim, identified as Pruthviraj Chavan (65), a resident of Kondhwa, has lodged an offence in this case at the Sinhagad police station. According to police, the accused persons came to Chavan’s clinic around 8.30 pm on Saturday seeking immediate treatment as one of them was injured. Chavan was already treating another patient and asked him to wait for some time.
The Indian Express
A 25-year-old doctor who completed his MBBS from AIIMS died Monday morning after having battled Covid for over a month. Dr Vikas Solanki, a resident of Hisar in Haryana, tested positive for the disease last month and had been availing treatment at a hospital there. He was shifted to the AIIMS campus in Jhajjar as his complications grew. On Saturday, Dr Solanki was shifted from the Jhajjar campus to AIIMS Trauma Centre in Delhi and was put on ventilator. Dr Ajay Mohan, a surgery resident at AIIMS, who was Solanki’s senior during their MBBS days at the Institute, said he died at 8.30 am at the Trauma Centre. Mohan said Solanki was initially “asymptomatic” and that the virus “first impacted his pancreas leading to hypoglycemia and sepsis. Slowly, his organs started shutting down. He underwent dialysis too — the condition of his lungs deteriorated and then on Monday morning, he passed away. He was a dynamic young man; it’s so heartbreaking and scary.”